A detailed history of Semmax Financial Advisors Inc. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Semmax Financial Advisors Inc. holds 14 shares of ALNY stock, worth $3,367. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14
Previous 14 -0.0%
Holding current value
$3,367
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022

SELL
$138.54 - $232.0 $111,801 - $187,224
-807 Reduced 98.29%
14 $3,000
Q2 2022

Aug 12, 2022

SELL
$120.42 - $169.29 $12,042 - $16,929
-100 Reduced 10.86%
821 $190,000
Q1 2022

May 11, 2022

SELL
$127.18 - $173.91 $9,156 - $12,521
-72 Reduced 7.25%
921 $150,000
Q4 2021

Mar 01, 2022

SELL
$159.56 - $209.29 $30,156 - $39,555
-189 Reduced 15.99%
993 $168,000
Q3 2021

Nov 10, 2021

SELL
$169.75 - $207.73 $23,425 - $28,666
-138 Reduced 10.45%
1,182 $223,000
Q2 2021

Aug 11, 2021

BUY
$128.63 - $176.89 $2,443 - $3,360
19 Added 1.46%
1,320 $224,000
Q1 2021

May 04, 2021

BUY
$126.83 - $175.69 $165,005 - $228,572
1,301 New
1,301 $184,000

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29.6B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Semmax Financial Advisors Inc. Portfolio

Follow Semmax Financial Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Semmax Financial Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Semmax Financial Advisors Inc. with notifications on news.